Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Prospective, Open Label Randomized Controlled Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07282912
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:18.374167+00:00
Published At
2026-03-04T00:00:00+00:00
Record Updated At
2026-03-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Foregut Adenocarcinoma", "Esophageal Adenocarcinoma", "Gastroesophageal Adenocarcinoma", "Gastric Adenocarcinoma", "Pancreas Adenocarcinoma", "Duodenal Adenocarcinoma", "Ampullary Adenocarcinoma", "Gallbladder Adenocarcinoma", "Intra - and Extrahepatic Cholangiocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-04"
protocolSection.identificationModule.nctId
"NCT07282912"
protocolSection.identificationModule.officialTitle
"Phase II Prospective, Open Label Randomized Controlled Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Foregut Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Esophageal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Gastroesophageal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Gastric Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Pancreas Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Duodenal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Ampullary Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Gallbladder Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Intra - and Extrahepatic Cholangiocarcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.